Medivolve Inc.

MEDVF

MEDVFMedivolve Inc. US flag

Other OTC

0.01

USD

- -

-0.07EPS

-0.10P/E

-NaNMarket Cap

Nov 12Next Earn

Upgrade to Unlock Non-US CompaniesTo view real-time data and analysis of companies outside of the United States, upgrade your account to our premium subscription.

Upgrade

ISIN

CA58503M4083

Return %

Stock

S&P500

-36.36

33.65

-98.73

33.66

-92.93

95.84

Use logarithmic scale

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	TTM
Revenue per Share	- -	- -	- -	- -	- -	- -	- -	- -	-0.07	1.59	4.49	0.05	0.03	0.03
Basic EPS, GAAP	-4.88	-7.48	-7.19	-4.54	-2.48	-0.59	1.39	-0.31	-1.19	-5.66	-0.34	-0.68	-0.61	-0.54
Free Cash Flow per Basic Share	-2.97	-6.93	-5.82	-1.41	-0.37	-0.84	1.52	-0.2	-1.08	-1.71	-0.43	0.22	-0.12	-0.04
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Book Value per Share	-19.24	-33.92	-39.45	-37.46	-39.24	-14.44	1.59	1.77	0.7	-2.07	0.31	-0.36	-0.94	-0.94
Tangible Book Value per Share	34.5	12.41	5.2	1.4	-1.1	1.62	2.31	1.99	0.87	-1.91	0.8	-0.04	-0.61	-0.65
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	1	2	2	2	7	19	27	27	27
Sales/Revenue/Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	11	87	1	1	1
Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	1,693.86	-80.79	15.79	-944.4	-491.38	-387.59
Depreciation Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	3	5	2	- -	- -
Net Income, GAAP	-2	-3	-3	-2	-1	-1	3	-1	-3	-38	-7	-18	-16	-14
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Profit Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	1,787.07	-356.96	-7.61	-1,322.72	-2,397.53	-1,572.02
Working Capital	6	3	1	- -	-1	1	5	4	2	-24	15	-1	-17	-18
LT Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	- -	- -	- -
Total Equity	13	5	2	1	-1	2	5	5	2	-10	18	- -	-16	-17
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	-108.77	- -	- -	- -	- -	- -	- -	- -
Return on Capital (%)	- -	- -	- -	- -	- -	- -	-42.32	- -	- -	- -	- -	- -	- -	- -
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	-18.58	-96.92	- -	- -	- -	- -	- -

Capital Structure

•

in mil. unless spec.

Working Capital

•

in mil. unless spec.

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)	10 years	5 years	1 year
Sales/Revenue/Turnover	- -	- -	-50.56%
Net Income, GAAP	90.49%	331.34%	-10.39%
Free Cash Flow	30.03%	89.66%	-151.83%
Total Cash Common Dividend	- -	- -	- -
Total Equity	-666.28%	-1,206.55%	-4,995.77%

Growth Rates

•

in mil. unless spec.

Quarterly Revenue

•

in mil. unless spec.

Quarterly Earnings Per Share

•

in mil. unless spec.

Quarterly Dividends Per Share

•

in mil. unless spec.

Company Description

CEO: Mr. Neil Said
Full Time Employees: 25
Sector: Healthcare
Industry: Medical - Diagnostics & Research
Address: 65 Queen Street West Toronto ON Canada M5H 2M5
IPO Date: Dec 18, 2009
Website: medivolve.ca
Similar Companies: Akumin Inc. (AKU.TO)
Genomic Vision Société Anonyme (GV.PA)
Aspira Women's Health Inc. (AWH)
Integrated Diagnostics Holdings plc (IDHC.L)
Cyclo3pss Corporation (CYPS)
MDxHealth SA (MDXH.BR)
Business: Medivolve Inc. is a principal investment firm. It prefers to invest in healthcare technology, industrials, information technology. Medivolve Inc., formerly known as QuestCap Inc, was founded in 2005 and is based in Toronto, Canada.

Company News

globenewswire.com
a month ago
Medivolve Announces Management Changes
globenewswire.com
8 months ago
Medivolve Announces Change of Auditor
proactiveinvestors.com
9 months ago
Medivolve announces telehealth platform development contract; management and director changes
globenewswire.com
9 months ago
Medivolve Announces Telehealth Platform Development Contract and Change of Officers and Directors
globenewswire.com
a year ago
Medivolve Announces Change of Auditor and Board Changes
globenewswire.com
a year ago
Medivolve Announces Board Changes
proactiveinvestors.com
a year ago
Medivolve establishes a management services organization in Puerto Rico
proactiveinvestors.com
2 years ago
Medivolve closes previously announced secured convertible note financing for aggregate gross proceeds of $1.2M

Company News

globenewswire.com
a month ago
Medivolve Announces Management Changes
globenewswire.com
8 months ago
Medivolve Announces Change of Auditor
proactiveinvestors.com
9 months ago
Medivolve announces telehealth platform development contract; management and director changes
globenewswire.com
9 months ago
Medivolve Announces Telehealth Platform Development Contract and Change of Officers and Directors
globenewswire.com
a year ago
Medivolve Announces Change of Auditor and Board Changes
globenewswire.com
a year ago
Medivolve Announces Board Changes
proactiveinvestors.com
a year ago
Medivolve establishes a management services organization in Puerto Rico
proactiveinvestors.com
2 years ago
Medivolve closes previously announced secured convertible note financing for aggregate gross proceeds of $1.2M

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	TTM
Revenue per Share	- -	- -	- -	- -	- -	- -	- -	- -	-0.07	1.59	4.49	0.05	0.03	0.03
Basic EPS, GAAP	-4.88	-7.48	-7.19	-4.54	-2.48	-0.59	1.39	-0.31	-1.19	-5.66	-0.34	-0.68	-0.61	-0.54
Free Cash Flow per Basic Share	-2.97	-6.93	-5.82	-1.41	-0.37	-0.84	1.52	-0.2	-1.08	-1.71	-0.43	0.22	-0.12	-0.04
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Book Value per Share	-19.24	-33.92	-39.45	-37.46	-39.24	-14.44	1.59	1.77	0.7	-2.07	0.31	-0.36	-0.94	-0.94
Tangible Book Value per Share	34.5	12.41	5.2	1.4	-1.1	1.62	2.31	1.99	0.87	-1.91	0.8	-0.04	-0.61	-0.65
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	1	2	2	2	7	19	27	27	27
Sales/Revenue/Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	11	87	1	1	1
Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	1,693.86	-80.79	15.79	-944.4	-491.38	-387.59
Depreciation Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	3	5	2	- -	- -
Net Income, GAAP	-2	-3	-3	-2	-1	-1	3	-1	-3	-38	-7	-18	-16	-14
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Profit Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	1,787.07	-356.96	-7.61	-1,322.72	-2,397.53	-1,572.02
Working Capital	6	3	1	- -	-1	1	5	4	2	-24	15	-1	-17	-18
LT Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	- -	- -	- -
Total Equity	13	5	2	1	-1	2	5	5	2	-10	18	- -	-16	-17
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	-108.77	- -	- -	- -	- -	- -	- -	- -
Return on Capital (%)	- -	- -	- -	- -	- -	- -	-42.32	- -	- -	- -	- -	- -	- -	- -
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	-18.58	-96.92	- -	- -	- -	- -	- -

Year	Q1	Q2	Q3	Q4	FY
2022	-0.05	-0.22	-0.26	- -	-0.68
2023	-0.11	-0.06	-0.13	- -	-0.61
2024	-0.03	- -	- -	- -	- -

	Sep'23	Dec'23	Mar'24
Total Current Assets	9	1	1
Accounts Receivable, Net	7	- -	- -
Cash, Cash Equivalents & STI	2	1	- -
Inventories	- -	- -	- -
Total Current Liabilities	17	18	19
Payables & Accruals	15	15	16
ST Debt	2	2	2
Deferred Revenue	- -	- -	- -

	Sep'23	Dec'23	Mar'24
ST Debt	2	2	2
LT Borrowings	- -	- -	- -
LT Finance Leases	- -	- -	- -
Preferred Equity and Hybrid Capital	- -	- -	- -
Shares Outstanding	27	27	27
Market Capitalization	2	- -	- -

Medivolve Inc.

Growth Rates

(avg. rate of change)

Company Description

Company News

Company News

Growth Rates

(avg. rate of change)

Quarterly Earnings Per Share

Year

Quarterly Dividends Per Share

Year

Quarterly Revenue

Year

Working Capital

Capital Structure